Is Sotorasib available in Paraguay?

There are no versions of Sotorasib (Sotorasib) currently produced and marketed in Paraguay. Sotorracib is an oral medication that belongs to a class of drugs known as KRAS G12C inhibitors. The KRAS gene plays an important role in regulating cell growth and signaling in human cells. However, the G12C mutation of the KRAS gene is closely related to the occurrence and development of various cancers, especially non-small cell lung cancer (NSCLC). Sotorasiib acts specifically on the KRAS G12C mutant protein, inhibits its activity, and blocks abnormal signal transduction pathways. This helps reduce the ability of cancer cells to proliferate and grow, thereby inhibiting tumor development.